OptimizeRx Reports Record Second Quarter 2019 Results; Total Revenue Up 37% to $7.0 Million, Net Income up 45% to $407,000 or $0.03 per Diluted Share
Stock Information for OptimizeRx Corporation
Loading
Please wait while we load your information from QuoteMedia.